Medical Director

Job ID
2017-1113
Category
Clinical Development
US-MA-Cambridge

Company Summary

The Medical Director will design and execute clinical development strategy for Jounce’s lead immune-oncology product candidate, JTX-2011, an agonist antibody to ICOS.  He or she will be responsible for all clinical activities related to JTX-2011 sponsored studies.  As Jounce grows and brings new drugs into the clinic, there will be an opportunity to take on more responsibility and play an important leadership role in the company.

Role / Responsibilities

Major Responsibilities include:

  • Protocol development
  • Study implementation
  • Medical Monitoring
  • Safety oversight
  • Primary contact with study investigators
  • Study enrollment
  • Data analysis and interpretation and primary author of clinical study reports
  • Clinical support to clinical operations, regulatory, research, and manufacturing functions
  • Clinical representative on Product Team and other cross-functional teams

Qualifications

Qualification and Education Requirements:

  • MD with at least 3 years of pharmaceutical or biotechnology industry experience in oncology clinical development; experience in early phase and in immuno-oncology preferred.
  • Board certified in internal medicine and medical oncology
  • In depth knowledge and experience with Good Clinical Practice

Preferred Skills:

  • Experience designing, conducting, serving as medical monitor, and analyzing data in Phase 1-2 clinical trials in oncology.
  • Experience with companion diagnostics
  • Experience interacting with Contract Research Organizations
  • Prior experience writing and submitting INDs to FDA; experience with pre-IND and EOP1 meetings preferred.
  • Ability to work in a high paced team environment, meet deadlines, & prioritize work on multiple projects
  • Strong verbal and written skills
  • History of strong relationships with academic investigators

To apply, please visit our website at https://careers-jouncetx.icims.com 

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed